Invention Grant
- Patent Title: Factor H for treatment of rheumatoid arthritis
- Patent Title (中): 因子H用于治疗类风湿性关节炎
-
Application No.: US14210091Application Date: 2014-03-13
-
Publication No.: US09248162B2Publication Date: 2016-02-02
- Inventor: Richard Johnson
- Applicant: Baxter International Inc. , Baxter Healthcare SA
- Applicant Address: US IL Bannockbum CH Glattpark (Opfikon)
- Assignee: Baxalta Incorporated,Baxalta GmbH
- Current Assignee: Baxalta Incorporated,Baxalta GmbH
- Current Assignee Address: US IL Bannockbum CH Glattpark (Opfikon)
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: A61K38/17
- IPC: A61K38/17 ; C07K14/00 ; A61P19/02 ; A61K38/13
Abstract:
The present invention provides a method for preventing or inhibiting allograft rejection by a recipient of that allograft by treating the recipient with a composition comprising Factor H (FH). The invention also encompasses methods in which the recipient is also administered one or more immunosuppressants in addition to the Factor H.
Public/Granted literature
- US20140336121A1 FACTOR H FOR TREATMENT OF RHEUMATOID ARTHRITIS Public/Granted day:2014-11-13
Information query
IPC分类:
